Ticagrelor vs. clopidogrel for coronary microvascular dysfunction in patients with STEMI: a meta-analysis of randomized controlled trials

PURPOSE: Approximately half of ST-segment elevation myocardial infarction (STEMI) patients who undergo revascularization present with coronary microvascular dysfunction. Dual antiplatelet therapy, consisting of aspirin and a P2Y12 inhibitor (e.g., clopidogrel or ticagrelor), is recommended to reduce...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yike, Ye, Zixiang, Guo, Ziyu, Xie, Enmin, Wang, Min, Zhao, Xuecheng, Liu, Mei, Li, Peizhao, Yu, Changan, Gao, Yanxiang, Zheng, Jingang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233131/
https://www.ncbi.nlm.nih.gov/pubmed/37273883
http://dx.doi.org/10.3389/fcvm.2023.1102717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233131/
https://www.ncbi.nlm.nih.gov/pubmed/37273883
http://dx.doi.org/10.3389/fcvm.2023.1102717

Ejemplares similares